Candriam S.C.A. Nurix Therapeutics, Inc. Transaction History

Candriam S.C.A.

$15.6 Billion
Q1 2025

A detailed history of Candriam S.C.A. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 588,931 shares of NRIX stock, worth $7.36 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

588,931

Previous 634,626 7.2%

Holding current value

$7.36 Million

Previous $12 Million 41.49%

% of portfolio

0.04%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$11.88 - $20.15 $542,856 - $920,754	-45,695 Reduced 7.2%	588,931 $7 Million
Q4 2024 Feb 06, 2025	SELL	$18.64 - $28.14 $7.97 Million - $12 Million	-427,333 Reduced 40.24%	634,626 $12 Million
Q3 2024 Nov 13, 2024	SELL	$18.93 - $25.69 $1.94 Million - $2.63 Million	-102,287 Reduced 8.79%	1,061,959 $23.8 Million
Q2 2024 Aug 05, 2024	BUY	$12.02 - $21.3 $3.27 Million - $5.8 Million	272,136 Added 30.5%	1,164,246 $24.3 Million
Q1 2024 May 03, 2024	SELL	$7.77 - $15.66 $202,020 - $407,160	-26,000 Reduced 2.83%	892,110 $13.1 Million
Q4 2023 Feb 14, 2024	SELL	$4.25 - $10.71 $212,500 - $535,500	-50,000 Reduced 5.16%	918,110 $9.47 Million
Q3 2023 Nov 13, 2023	SELL	$7.86 - $10.08 $406,456 - $521,256	-51,712 Reduced 5.07%	968,110 $7.61 Million
Q2 2023 Aug 08, 2023	BUY	$8.7 - $13.28 $1.04 Million - $1.59 Million	119,734 Added 13.3%	1,019,822 $10.2 Million
Q1 2023 May 12, 2023	BUY	$8.56 - $13.26 $423,831 - $656,542	49,513 Added 5.82%	900,088 $7.99 Million
Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $246,500 - $364,750	25,000 Added 3.03%	850,575 $9.34 Million
Q3 2022 Nov 10, 2022	SELL	$12.33 - $19.81 $170,154 - $273,378	-13,800 Reduced 1.64%	825,575 $10.8 Million
Q2 2022 Aug 03, 2022	BUY	$7.88 - $14.82 $585,239 - $1.1 Million	74,269 Added 9.71%	839,375 $10.6 Million
Q1 2022 May 13, 2022	SELL	$12.94 - $29.65 $375,221 - $859,761	-28,997 Reduced 3.65%	765,106 $10.7 Million
Q4 2021 Feb 10, 2022	BUY	$26.43 - $34.5 $6.32 Million - $8.25 Million	239,107 Added 43.08%	794,103 $23 Million
Q3 2021 Nov 09, 2021	BUY	$22.71 - $36.69 $1.08 Million - $1.75 Million	47,693 Added 9.4%	554,996 $16.6 Million
Q2 2021 Jul 20, 2021	BUY	$24.21 - $35.89 $12.3 Million - $18.2 Million	507,290 Added 3902230.75%	507,303 $13.5 Million
Q1 2021 Apr 29, 2021	BUY	$26.98 - $50.17 $350 - $652	13 New	13 $0

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

74.4M

Call Options Held

56.9K

Put Options Held

7.9K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $589M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account